May 13, 2024 04:01PM
May 6, 2024 07:00AM
Apr 2, 2024 07:00AM
Mar 7, 2024 07:00AM
Mar 4, 2024 04:01PM
Feb 12, 2024 04:01PM
Jan 22, 2024 07:04AM Cara Therapeutics (CARA) Prioritizes Late-Stage Notalgia Paresthetica Program, Extends Cash Runway into 2026
Jan 22, 2024 07:00AM
Dec 18, 2023 07:04AM
Dec 18, 2023 07:00AM
Nov 13, 2023 04:01PM
Nov 2, 2023 07:01AM
Nov 2, 2023 07:00AM
Oct 23, 2023 07:00AM Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
Sep 25, 2023 07:01AM
Sep 25, 2023 07:00AM
Sep 5, 2023 07:00AM
Aug 7, 2023 04:01PM
Aug 3, 2023 07:01AM
Aug 3, 2023 07:00AM
Aug 2, 2023 07:00AM Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
Jul 24, 2023 07:00AM
Jun 1, 2023 07:00AM
May 15, 2023 04:01PM
May 1, 2023 07:00AM
May 1, 2023 07:00AM
Apr 10, 2023 07:00AM
Apr 10, 2023 07:00AM Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
Mar 14, 2023 07:00AM
Mar 14, 2023 07:00AM
Mar 6, 2023 04:01PM
Mar 6, 2023 04:01PM
Feb 21, 2023 07:00AM
Feb 21, 2023 07:00AM
Feb 8, 2023 05:01PM Cara Therapeutics (CARA) Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in NEJM
Feb 8, 2023 05:00PM
Feb 8, 2023 05:00PM
Jan 17, 2023 07:00AM
Jan 17, 2023 07:00AM
Jan 3, 2023 07:00AM
Jan 3, 2023 07:00AM
Nov 29, 2022 07:33AM KemPharm (KMPH) Announces Appointment of Christopher Posner as New Independent Director
Nov 29, 2022 07:30AM
Nov 7, 2022 04:01PM
Nov 7, 2022 04:01PM
Nov 3, 2022 07:05AM
Nov 3, 2022 07:00AM
Nov 3, 2022 07:00AM
Nov 2, 2022 07:00AM Cara Therapeutics to Present at Upcoming Investor Conferences
Nov 2, 2022 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All